0ILL fundamentals
LABORATORIOS FARMACEUTOCOS ROVI SA EUR0.06 earnings per share and revenue
Company revenue for the same period amounts to 235.30 M EUR despite the estimated figure of 229.78 M EUR. Also watch annual changes over time to get a bigger picture of 0ILL earnings per share and revenue dynamics.
Next report date
≈
Mar 04, 2025Report periodQ4 2024
EPS estimate—
Revenue estimate—
EPS
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Q1 '25
0.00
0.13
0.26
0.39
0.52
Reported
Estimate
Currency: EUR
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Q1 '25
Reported
0.51
—
—
—
—
—
—
—
—
—
Estimate
—
—
—
—
—
—
—
—
—
—
Surprise
—
—
—
—
—
—
—
—
—
—
Revenue
Forecast
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Q1 '25
0.00
70.00 M
140.00 M
210.00 M
280.00 M
Reported
Estimate
Currency: EUR
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q3 '24
Q4 '24
Q1 '25
Reported
174.80 M
198.50 M
242.00 M
202.00 M
179.00 M
214.05 M
235.00 M
235.30 M
—
—
Estimate
172.00 M
194.20 M
219.60 M
194.30 M
174.53 M
210.56 M
223.60 M
229.78 M
—
—
Surprise
+1.63%
+2.21%
+10.20%
+3.96%
+2.56%
+1.66%
+5.10%
+2.40%
—
—